Jext (Epinephrine Bitartrate)

Epinephrine stimulates both alpha and beta adrenergic receptors. Alpha‑1 activation causes blood‑vessel constriction, raising blood pressure; beta‑1 activation increases heart rate and contractility; beta‑2 activation relaxes airway smooth muscle and reduces mediator release, together counteracting anaphylactic processes.

The dose of Jext is determined by the prescribing clinician based on the patient’s age, weight, severity of the reaction, and clinical guidelines. The product is supplied as a pre‑measured injection, and the prescriber decides the appropriate amount and any repeat dosing.

The safety of epinephrine in pregnancy and lactation has not been definitively established. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To order Jext, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Jext delivers epinephrine, the first‑line drug for anaphylaxis, similar to other epinephrine autoinjectors. Its intramuscular injection provides the same rapid onset of action. Differences may lie in device design, packaging, and regulatory approvals, but the pharmacologic effect of epinephrine remains consistent across products.

Jext should be stored at 2‑8 °C (refrigerated). Keep it in the original packaging, protect it from light, and avoid freezing or shaking the vial. Do not store at ambient temperatures for prolonged periods, as potency may be reduced.

Jext is administered by intramuscular injection, typically into the anterolateral thigh. The injection should be given promptly when anaphylaxis is suspected, using the supplied needle and following aseptic technique. If symptoms persist, a second dose may be given after 5‑15 minutes under medical supervision.

Serious risks include cardiac arrhythmias, severe hypertension, myocardial ischemia, and tissue necrosis at the injection site. These events are rare but require immediate medical attention. Patients should be monitored for cardiovascular changes after administration.

Jext is contraindicated in patients with known hypersensitivity to epinephrine or any excipients in the formulation. Caution is advised in individuals with significant cardiac disease, uncontrolled hypertension, or hyperthyroidism, and it should be avoided in those taking non‑selective beta‑blockers without medical supervision.